Fortitude Family Office’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.22K Buy
+361
New +$6.21K ﹤0.01% 1539
2026
Q2
– Sell
-26
Closed -$454 – 2382
2026
Q1
$454 Hold
26
– – ﹤0.01% 1764
2025
Q4
$510 Sell
26
-153
-85% -$3.17K ﹤0.01% 1704
2025
Q3
$4.93K Sell
179
-17
-9% -$523 ﹤0.01% 815
2025
Q2
$5.98K Buy
+196
New +$5.57K ﹤0.01% 732

Other funds holding USNA

Fortitude Family Office's USNA Position: Q3 2026 in Review

Fortitude Family Office opened a new position in Usana Health Sciences (USNA) in Q3 2026: 361 shares worth $5.22K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in USNA as recently as Q1 2026.

Fortitude Family Office first reported a position in USNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.98K in Q2 2025. 8 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Fortitude Family Office held 361 shares of Usana Health Sciences worth $5.22K as of Q3 2026.
  • Usana Health Sciences was a new Fortitude Family Office position in Q3 2026.
  • Usana Health Sciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1539 holding.
  • Fortitude Family Office first reported a position in Usana Health Sciences in Q2 2025 and has held it in 5 quarters since.
  • Fortitude Family Office's Usana Health Sciences position peaked at $5.98K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.